Jane Street’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.94M | Buy |
384,957
+52,486
| +16% | +$669K | 0.01% | 3540 |
|
|
2025
Q4 | $2.99M | Buy |
332,471
+132,372
| +66% | +$1.82M | ﹤0.01% | 4045 |
|
|
2025
Q3 | $3.46M | Sell |
200,099
-12,731
| -6% | -$157K | ﹤0.01% | 3995 |
|
|
2025
Q2 | $2M | Buy |
212,830
+64,795
| +44% | +$532K | ﹤0.01% | 4416 |
|
|
2025
Q1 | $1.05M | Sell |
148,035
-107,221
| -42% | -$1.08M | ﹤0.01% | 5477 |
|
|
2024
Q4 | $2.98M | Buy |
255,256
+19,129
| +8% | +$299K | ﹤0.01% | 3457 |
|
|
2024
Q3 | $4.85M | Sell |
236,127
-9,299
| -4% | -$214K | 0.01% | 2910 |
|
|
2024
Q2 | $5.49M | Buy |
245,426
+151,594
| +162% | +$3.61M | 0.01% | 2834 |
|
|
2024
Q1 | $2.58M | Sell |
93,832
-110,453
| -54% | -$3.07M | ﹤0.01% | 3666 |
|
|
2023
Q4 | $6.23M | Buy |
204,285
+116,308
| +132% | +$3.34M | 0.01% | 2554 |
|
|
2023
Q3 | $2.78M | Sell |
87,977
-116,862
| -57% | -$4.53M | ﹤0.01% | 3492 |
|
|
2023
Q2 | $8.35M | Buy |
204,839
+156,638
| +325% | +$6.35M | 0.01% | 2110 |
|
|
2023
Q1 | $1.8M | Sell |
48,201
-12,822
| -21% | -$503K | ﹤0.01% | 4011 |
|
|
2022
Q4 | $2.13M | Buy |
61,023
+30,092
| +97% | +$1.43M | ﹤0.01% | 3777 |
|
|
2022
Q3 | $1.73M | Sell |
30,931
-9,119
| -23% | -$566K | ﹤0.01% | 4442 |
|
|
2022
Q2 | $2.07M | Buy |
40,050
+18,503
| +86% | +$940K | ﹤0.01% | 4096 |
|
|
2022
Q1 | $1.57M | Sell |
21,547
-13,367
| -38% | -$1.13M | ﹤0.01% | 5223 |
|
|
2021
Q4 | $4.13M | Buy |
34,914
+15,153
| +77% | +$1.9M | 0.01% | 3156 |
|
|
2021
Q3 | $2.65M | Sell |
19,761
-31,938
| -62% | -$4.84M | 0.01% | 3906 |
|
|
2021
Q2 | $8.37M | Sell |
51,699
-6,578
| -11% | -$512K | 0.02% | 1921 |
|
|
2021
Q1 | $4.68M | Sell |
58,277
-47,034
| -45% | -$3.16M | 0.01% | 2500 |
|
|
2020
Q4 | $5.73M | Buy |
105,311
+73,549
| +232% | +$2.67M | 0.02% | 1970 |
|
|
2020
Q3 | $631K | Buy |
31,762
+20,584
| +184% | +$429K | ﹤0.01% | 4810 |
|
|
2020
Q2 | $235K | Buy |
+11,178
| New | +$190K | ﹤0.01% | 6175 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
